- 阻害剤
- 研究分野別
- PI3K/Akt/mTOR
- Epigenetics
- Methylation
- Immunology & Inflammation
- Protein Tyrosine Kinase
- Angiogenesis
- Apoptosis
- Autophagy
- ER stress & UPR
- JAK/STAT
- MAPK
- Cytoskeletal Signaling
- Cell Cycle
- TGF-beta/Smad
- 化合物ライブラリー
- 抗体
- 新製品
- お問い合わせ
LTR
亜型選択性的な製品
LTR製品
- All (9)
- LTR阻害剤 (1)
- LTR拮抗剤(8)
- 新製品
| 製品コード | 製品名称 | 製品説明 | 文献中Selleckの製品使用例 | お客様のフィードバック |
|---|---|---|---|---|
| S8126 | MK571 | MK571 is a selective, orally active CysLT1 receptor(Cysteinyl leukotriene receptor) antagonist. |
|
|
| S4211 | Montelukast Sodium | Montelukast Sodium selectively antagonizes leukotriene D4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1. Montelukast improves macroautophagy but not the chaperone-mediated autophagy pathway. Solutions are unstable and should be fresh-prepared. | ||
| S1633 | Zafirlukast | Zafirlukast is an oral leukotriene receptor antagonist (LTRA), used to prevent asthma symptoms. | ||
| S5783 | Montelukast | Montelukast(MK0476) is a leukotriene receptor antagonist used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. | ||
| S0505 | MK-571 sodium salt | MK-571 sodium salt (L-660711) is a selective, orally active antagonist of leukotriene D4 receptor. It is also an inhibitor of multidrug resistance-associated protein MRP4 (ABCC4) and ABCC1 (MRP1). | ||
| S3998 | (+)-α-Lipoic acid | (+)-α-Lipoic acid ((R)-(+)-α-Lipoic acid, α-Lipoic acid, Alpha-Lipoic acid), a physiological form of thioctic acid, is a strong antioxidant that relieves diabetic neuropathic symptoms. It shows superior antioxidative effects to its racemate. R(+)-α-lipoic acid is an essential cofactor of mitochondrial enzyme complexes. R(+)-α-lipoic acid inhibits NF-κB-dependent HIV-1 LTR activation. | ||
| E2671 | SR 2640 hydrochloride | SR2640 hydrochloride is a potent and selective competitive leukotriene D4/E4 antagonist. | ||
| S0428 | Etalocib | Etalocib(LY293111, VML295) is a leukotriene B4 receptor (LTB4R) antagonist that blocks activation of human neutrophils. | ||
| S2959 | LY255283 | LY255283 is an antagonist of leukotriene B4 (LTB4) receptor (BLT2) that displaces [3H]LTB4 from its binding site on lung membranes with pKi of 7.0. | ||
| S3998 | (+)-α-Lipoic acid | (+)-α-Lipoic acid ((R)-(+)-α-Lipoic acid, α-Lipoic acid, Alpha-Lipoic acid), a physiological form of thioctic acid, is a strong antioxidant that relieves diabetic neuropathic symptoms. It shows superior antioxidative effects to its racemate. R(+)-α-lipoic acid is an essential cofactor of mitochondrial enzyme complexes. R(+)-α-lipoic acid inhibits NF-κB-dependent HIV-1 LTR activation. | ||
| S8126 | MK571 | MK571 is a selective, orally active CysLT1 receptor(Cysteinyl leukotriene receptor) antagonist. |
|
|
| S4211 | Montelukast Sodium | Montelukast Sodium selectively antagonizes leukotriene D4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1. Montelukast improves macroautophagy but not the chaperone-mediated autophagy pathway. Solutions are unstable and should be fresh-prepared. | ||
| S1633 | Zafirlukast | Zafirlukast is an oral leukotriene receptor antagonist (LTRA), used to prevent asthma symptoms. | ||
| S5783 | Montelukast | Montelukast(MK0476) is a leukotriene receptor antagonist used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. | ||
| S0505 | MK-571 sodium salt | MK-571 sodium salt (L-660711) is a selective, orally active antagonist of leukotriene D4 receptor. It is also an inhibitor of multidrug resistance-associated protein MRP4 (ABCC4) and ABCC1 (MRP1). | ||
| E2671 | SR 2640 hydrochloride | SR2640 hydrochloride is a potent and selective competitive leukotriene D4/E4 antagonist. | ||
| S0428 | Etalocib | Etalocib(LY293111, VML295) is a leukotriene B4 receptor (LTB4R) antagonist that blocks activation of human neutrophils. | ||
| S2959 | LY255283 | LY255283 is an antagonist of leukotriene B4 (LTB4) receptor (BLT2) that displaces [3H]LTB4 from its binding site on lung membranes with pKi of 7.0. |
LTR阻害剤の選択性比較
Tags: LTR inhibitor|LTR agonist|LTR activator|LTR inducer|LTR antagonist|LTR signaling pathway|LTR assay kit
納期 国内在庫品：受注日の翌日（15時までの受注分） ＊北海道、九州、沖縄への配送は受注日より２日以上 を要する場合あり 海外在庫品：受注後１〜２週間